Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Let us face it!

Let us face it!

posted on Sep 29, 2009 03:34AM

This matter doesn’t pay off as we expected. If there would be sustainable recoverability to be generated from a now waterproof 336-patent we really would see other levels of stock prices. Something doesn’t work as it should. I wonder what it is... Infringers who are aware of their impending payment obligation would stock up on ptsc-shares as much as they can, and you (and me) are not the only people in this world who are able to recognize huge potentials. Could it be that those potentials are not good enough by half as we want them so bad? I hope an error in reasoning is on my side. But I see what I see – pragmatically.

GLTA drb

Share
New Message
Please login to post a reply